GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 355 filers reported holding GUARDANT HEALTH INC in Q1 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $281,000 | +28.3% | 5,209 | -3.9% | 0.02% | +27.8% |
| Q2 2022 | $219,000 | -42.7% | 5,421 | -6.0% | 0.02% | -28.0% |
| Q1 2022 | $382,000 | -31.2% | 5,769 | +4.1% | 0.02% | -28.6% |
| Q4 2021 | $555,000 | -17.3% | 5,544 | +3.3% | 0.04% | -22.2% |
| Q3 2021 | $671,000 | +0.3% | 5,369 | -0.4% | 0.04% | 0.0% |
| Q2 2021 | $669,000 | -18.7% | 5,389 | 0.0% | 0.04% | -22.4% |
| Q1 2021 | $823,000 | +11.5% | 5,389 | -5.9% | 0.06% | +16.0% |
| Q4 2020 | $738,000 | +11.0% | 5,724 | -3.8% | 0.05% | -12.3% |
| Q3 2020 | $665,000 | +40.0% | 5,949 | +1.6% | 0.06% | +26.7% |
| Q2 2020 | $475,000 | +17.3% | 5,855 | +0.7% | 0.04% | -22.4% |
| Q1 2020 | $405,000 | -11.2% | 5,815 | -0.4% | 0.06% | +18.4% |
| Q4 2019 | $456,000 | +35.7% | 5,840 | +10.8% | 0.05% | +28.9% |
| Q3 2019 | $336,000 | -23.1% | 5,270 | +4.2% | 0.04% | -25.5% |
| Q2 2019 | $437,000 | +104.2% | 5,060 | +81.7% | 0.05% | +88.9% |
| Q1 2019 | $214,000 | – | 2,785 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |